Clinical Trial Update: The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of vericiguat on peripheral vascular function, patient health status, and inflammation in heart failure with reduced ejection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Vericiguat (vericiguat)

Snippet

Sponsor: Josef Stehlik | Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF) | Phase 4 | Status: COMPLETED | Results posted: 2025-10-08